Business Wire

Mavenir Extends AI and Analytics Portfolio to Enable Mobile Network Optimization, Automation & Security

11.3.2021 17:00:00 EET | Business Wire | Press release

Share

Mavenir, the industry’s only end-to-end cloud-native Network Software Provider and a leader in accelerating software network transformation for communications service providers (CSPs), announced today its extended Artificial Intelligence (AI) and Analytics portfolio to enable closed-loop automation and drive digital transformation.

AI and machine learning (ML) in mobile network infrastructure is expected to lower costs by automating functions that typically require human interaction and to speed new revenue generating service offerings, becoming increasingly important as edge, open radio access networks (Open RAN), and 5G cores get deployed.

Mavenir’s AI and Analytics portfolio includes solutions designed to analyze and derive inferences from vast amounts of unstructured data to automate networks, achieve cost savings, and build out 5G use cases. Many Industry 4.0 use cases such as Intelligent Video Analytics and AR/VR are enabled by 5G that require AI-driven inferences at the edge. Mavenir’s portfolio includes these AI-enabled applications for Network Automation, Intelligent Operations, EdgeAI, and Network Security.

1)

 

Network Automation: Mavenir’s RAN Intelligent Controller (RIC) and Network Data Analytics Function (NWDAF) follow the specifications introduced by the O-RAN Alliance and 3GPP and operate as the heart of a network automation vision. The RIC and NWDAF enable the network to dynamically adapt to traffic conditions using machine learning (ML)-based algorithms and applications that can be deployed in any network in a multi-vendor environment. Mavenir’s containerized RIC and NWDAF product capabilities include:

 

  • Non-RT RIC: designed to host advanced ML algorithms (rApps) to optimize network performance and train ML models using long-term RAN data for dynamic and adaptive policy for RAN performance optimization.
  • Near-RT RIC: designed to host trained AI/ML models (xApps) to infer and control O-RAN functional elements in near-real time.
  • NWDAF: designed to ingest data from 5G standalone (SA) network functions and to provide various analytics and intelligence services for smart network operation.

2)

 

Intelligent Operations: By automating network operational processes with AI and analytics solutions, operators should be able to substantially reduce the cost and time from traditional, more labor-intensive methods such as drive testing, log inspection, troubleshooting, and manual calibration. With AI-based prediction engines, operators can achieve intelligent capacity planning and reduce the possibility of large-scale network outages. With anomaly detection capability, operators can uncover underlying network faults that are not easily visible. This AI-driven Operations (AIOps) solution using ML techniques plays a key role in reducing operating expenses and gives operators complete control over their networks.

 

 

3)

 

5G EdgeAI: Mavenir’s 5G EdgeAI solution includes Intelligent Video Analytics that can support myriad of use cases from facial recognition to anomaly detection for smart city and industry 4.0 use cases. Next generation of AR/VR applications are accelerated and enhanced by this edge platform. Large number of sensor data gets analyzed and actions are taken in a matter of milliseconds by the edge Industrial Internet of Things (IIoT) analytics application.

 

 

 

“AI is the key driver for Industry 4.0, providing real-time insights & control of industrial processes. Low latency, high density of 5G are also enablers, so in essence, the combination of 5G and AI = Industry 4.0,” said Kuntal Chowdhury, SVP and GM, Mavenir AI and Analytics Business Unit. “While Mavenir’s AI and Analytics solutions are now available as standalone solutions, we have been offering intelligent insights as integrated solutions to Tier 1 customers around the world for years. Currently over 200 systems are deployed in more than 80 customer networks and our solutions process and analyze billions of records per day, offering real-time/near-real-time insights to optimize network performance with little to no human intervention.”

 

 

4)

 

Network security: As new vulnerabilities arise, Mavenir’s Fraud Management and Security Suite protect the network in real-time with predictive analytics and ML. The Real-Time Fraud Management and Security analytics is leveraging unique ML algorithms and a specifically designed framework suited to manage the volume, velocity, and variety of structured and unstructured data over wireless networks.

 

 

 

“Mavenir Security and Anti-Fraud Solutions based on AI/ML are taking care of on-going revenue savings at Telefónica Argentina,” says Diego Quevedo, Core Network Solution Design Lead, Telefónica Argentina. “We are in close cooperation with Mavenir to ensure the up-to-date protection of our network.”

 

 

 

“Mavenir’s approach of applying Real-Time Machine Learning technology to protect key operator services and revenue has been highly valued by customers,” said Ilia Abramov, VP and GM, Mavenir Security BU. “New threats raised in the recent years and increasing attack vectors on Mobile Network Services have been successfully detected and blocked though our installed base. The increased level of trust of our AI/ML technology has been confirmed with substantial growth in additional network implementations in the last year.”

“Leveraging our deep AI/ML knowledge and advanced capabilities enables Communications Service Providers to optimize, automate and advance their mobile networks for the future of 5G,” said BG Kumar, President, Mavenir’s Communications Services Business Group. “Network automation and service protection driven by AI/ML are core capabilities of Mavenir and one of the highest priorities of our customers, and we are proud to provide this solution set to enable them to realize their vision.”

Mavenir’s AI/ML and Analytics solutions and Fraud/Security solutions are deployed at multiple Tier 1 operator networks across North America, EMEA, and APAC regions. Additionally, Mavenir is dedicated to continuous AI/ML innovation through the R&D Center of Excellence in Brno, Czech Republic, and R&D in Richardson TX and Bangalore, India.

About Mavenir:

Mavenir is the industry's only end-to-end, cloud-native Network Software and Solutions/Systems Integration Provider, focused on accelerating software network transformation. Mavenir offers a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack for communications service providers and enterprises. From 5G application layers (VoLTE, Messaging) to Packet Core and RAN, Security, Edge Analytics and AI, Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users.

Leveraging innovations in Mobile Core with IMS (VoLTE, VoWiFi, Advanced Messaging/RCS), and Packet Core (vEPC, 5G Core) as well as Radio Access/Edge (OpenRAN), Private Networks, as well as Mobile Services and Applications such as Digital Enablement. Mavenir accelerates digital network transformation for more than 250+ CSP customers in over 120 countries, which serve over 50% of the world’s subscribers. www.mavenir.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Maryvonne Tubb
Mavenir
PR@mavenir.com

Loren Guertin
MatterNow
mavenir@matternow.com

Kevin Taylor
GlobalResultsPR
mavenir@globalresultspr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye